Annunziata Gloghini

What is she best known for?

The fields of study she is best known for:

• Cancer
• Gene
• Internal medicine

Annunziata Gloghini mainly investigates Lymphoma, Pathology, Cancer research, Immunology and Virus. The Lymphoma study combines topics in areas such as Germinal center, Herpesviridae and Virology. Her biological study spans a wide range of topics, including Epstein–Barr virus and Non-Hodgkin's lymphoma.

Annunziata Gloghini has included themes like Molecular biology and Lymphocyte in her Pathology study. The concepts of her Cancer research study are interwoven with issues in Cell culture, DNA methylation, Gene expression profiling, CD8 and Methyltransferase. Her work on Lymphoproliferative disorders, Antigen and Bone marrow as part of general Immunology study is frequently connected to Population, therefore bridging the gap between diverse disciplines of science and establishing a new relationship between them.

Her most cited work include:

• Hypermethylation of the DNA repair gene O6-methylguanine DNA methyltransferase and survival of patients with diffuse large B-cell lymphoma (274 citations)
• HIV-associated lymphomas and gamma-herpesviruses (267 citations)
• Expression profile of MUM1/IRF4, BCL-6, and CD138/syndecan-1 defines novel histogenetic subsets of human immunodeficiency virus–related lymphomas (230 citations)

What are the main themes of her work throughout her whole career to date?

Lymphoma, Pathology, Cancer research, Immunology and Internal medicine are her primary areas of study. Her Lymphoma research is multidisciplinary, incorporating elements of Virus, Epstein–Barr virus, Virology and Herpesviridae. Her Pathology research incorporates themes from Immunophenotyping and Germinal center.

In her study, Reed–Sternberg cell is inextricably linked to Cell culture, which falls within the broad field of Cancer research. Her studies in Lymphoproliferative disorders, Antigen, B cell, Hepatitis C virus and Pathogenesis are all subfields of Immunology research. In her work, Colorectal cancer is strongly intertwined with Oncology, which is a subfield of Internal medicine.

She most often published in these fields:

• Lymphoma (43.55%)
• Pathology (37.33%)
• Cancer research (24.42%)

What were the highlights of her more recent work (between 2014-2021)?

• Internal medicine (16.36%)
• Oncology (11.29%)
• Cancer research (24.42%)

In recent papers she was focusing on the following fields of study:

Her primary areas of study are Internal medicine, Oncology, Cancer research, Pathology and Colorectal cancer. Her study on Oncology also encompasses disciplines like

• KRAS that connect with fields like Bioinformatics,
• Clinical trial that intertwine with fields like Primary tumor. Her study in Cancer research is interdisciplinary in nature, drawing from both Classical Hodgkin lymphoma, Cytokine, Cell growth, Blockade and microRNA.

Annunziata Gloghini works mostly in the field of Blockade, limiting it down to concerns involving Tumor microenvironment and, occasionally, Lymphoma. Her study looks at the intersection of microRNA and topics like Melanoma with Immunology. Molecular pathology is closely connected to Epithelial–mesenchymal transition in her research, which is encompassed under the umbrella topic of Pathology.

Between 2014 and 2021, her most popular works were:

• Heterogeneity of Acquired Resistance to Anti-EGFR Monoclonal Antibodies in Patients with Metastatic Colorectal Cancer (95 citations)
• A lymphomagenic role for HIV beyond immune suppression (59 citations)
• MET-Driven Resistance to Dual EGFR and BRAF Blockade May Be Overcome by Switching from EGFR to MET Inhibition in BRAF-Mutated Colorectal Cancer (57 citations)

In her most recent research, the most cited papers focused on:

• Cancer
• Gene
• Internal medicine

Annunziata Gloghini focuses on Internal medicine, Cancer research, Oncology, Immunology and Colorectal cancer. Her Internal medicine study frequently involves adjacent topics like Pathology. Annunziata Gloghini has researched Pathology in several fields, including Phenotype and Malignant Peritoneal Mesothelioma.

Her Cancer research study combines topics in areas such as Macrophage migration inhibitory factor, Cytokine, Cell growth and Blockade. Her Oncology research integrates issues from Survival rate, Prospective cohort study, Phases of clinical research and Clinical endpoint. Her Epstein–Barr virus, Lymphoma, Virus, Oncovirus and Pathogenesis study are her primary interests in Immunology.